Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF versus azathioprine for induction remission in treatment-naive autoimmune hepatitis
NL-OMON52983Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil, azathioprine and prednisolone in autoimmune hepatitis (AIH) (2 arms), sponsored by Leiden University Medical Center. Started Jan 2017; status: active, not recruiting.
02
Drugs
mycophenolate mofetilazathioprineprednisolone
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NL-OMON52983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52983.